JPRN-UMIN000041153
Recruiting
未知
Establishment of the method for predicting clinical effect of tocilizumab based on its serum concentration in rheumatoid arthritis patients - Establishment of the method for predicting clinical effect of tocilizumab based on its serum concentration in rheumatoid arthritis patients
Department of Hospital pharmacy Hamamatsu University School of Medicine0 sites50 target enrollmentJuly 19, 2020
Conditionsrheumatoid arthritis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- rheumatoid arthritis
- Sponsor
- Department of Hospital pharmacy Hamamatsu University School of Medicine
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients discontinuing tocilizumab. 2\. Patients who are judged by physicians as inappropriate for study enrollment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Establishment of a method for predicting therapeutic efficacy and adverse effects of drug therapy for hepatocellular carcinoma using tests related to the intestinal microbiota and elucidation of the mechanismChronic Hepatitis, Hepatocellular Carcinoma, Liver cirrhosisJPRN-UMIN000052641agoya University100
Recruiting
Not Applicable
A study to establish a prognosis prediction method for cochlear implants using resting fMRI and structural MRI auditory central target analysisJPRN-UMIN000042153ational Hospital Organization Tokyo Medical Center150
Not yet recruiting
Not Applicable
Development of a prediction models for clinical outcomes of patients with peritoneal dialysis based on home-based monitoring : Using deep learning methodsDiseases of The genitoruinary systemKCT0005608Yonsei University Health System, Severance Hospital100
Completed
Not Applicable
Establishment of clinical prediction models using machine learning techniques and predictive factors to predict adverse drug events in patients treated with dolutegravir-based anti-retroviral agentsHIV-infected patients under a DTG-based regimenadverse drug events, dolutegravir, machine learning, prediction model, HIVsTCTR20230904001Pakchongnana Hospital840
Unknown
Not Applicable
Investigation of method for prediction of therapeutic effect of adalimumab initial therapy for inflammatory bowel diseaselcerative colitis, Crohn's diseaseJPRN-UMIN000022727Ofuna Chuo Hospital20